Price to Sales ratio Analysis of Biogen Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
3.26
Period Ending - Dec-22
Very Poor PS
3.31
Growth
-1.40 %
Trailing Twelve Months PS
Period Ending - Dec-23
Poor PS
2.97
PS Analysis of Biogen Inc
PS Ratio of BIIB has fallen by -1.40 % Compared to previous Financial Year. |
PS Ratio with value of 3.31 was highest in Year Dec-22 in last Five Years. |
PS Ratio with value of 2.70 was lowest in Year Dec-20 in last Five Years. |
Latest PS Ratio with value of 3.26 is Greater than Average PS of 3.05 in last five years. |
Other PS Related Info of BIIB that may interest you.
Biogen Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
BIIB | 224.94 | 220.07 | 2.21 % | Drug Manufacturers-General |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Very Low Value Stock |
FY - Historical Price to Sales of Biogen Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
PS | 3.26 | 3.31 | 3.06 | 2.70 | 2.93 | 3.43 | 3.90 |
Change | -1.40 % | 7.95 % | 13.55 % | -7.95 % | -14.59 % | -12.06 % | -9.20 % |
FY Chart of Price to Sales of Biogen Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)